Accumulating evidence indicates that the PI3K/AKT/mTOR signaling pathway plays a pivotal role in the regulation of breast cancer growth, survival, and motility as well as the acquisition of drug resistance, and there are now extensive data indicating that various components of this pathway as potential molecular targets for breast cancer treatment [4]. The gene discussed is AKT1; the disease is breast cancer.